China SXT Pharmaceuticals (SXTC) Cash & Equivalents Growth (1y) (2019 - 2026)
China SXT Pharmaceuticals (SXTC) Cash & Equivalents Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 69.13% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 2.86% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 19.56% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 13.19% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 56.51% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 25.91% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | -1.67% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | -4.65% |
| 10 | China SXT Pharmaceuticals | 34,451.28 | -28.14 Mn | - | 55.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.42% |
| Sep 30, 2025 | 14.33% |
| Mar 31, 2025 | 50.11% |
| Sep 30, 2024 | 6.59% |
| Mar 31, 2024 | -30.46% |
| Sep 30, 2023 | 11.55% |
| Mar 31, 2023 | 11.55% |
| Sep 30, 2022 | 16.55% |
| Mar 31, 2022 | 16.55% |
| Sep 30, 2021 | 29.03% |
| Mar 31, 2021 | 83.33% |
| Sep 30, 2020 | 11.42% |
| Mar 31, 2020 | -21.58% |
| Sep 30, 2019 | 2,322.26% |
| Mar 31, 2019 | 1,312.65% |